The Pharma Data

MAY 7, 2021

Massachusetts sues Publicis for designing ‘marketing schemes’ to boost OxyContin sales ( STAT ). Catalent snaps up Promethera’s cell therapy subsidiary, complete with a Belgian plant to help scale plasmid DNA efforts ( Endpoints ). The US opened pandora’s box on IP waivers for Covid-19 vaccines.

Vaccine 52

Vaccine Compounding Pharmacies Regulations Drugs 52

Alta Sciences

MAY 15, 2023

TOP 5 WAYS INTEGRATED DRUG DEVELOPMENT SOLUTIONS SAVE YOU TIME AND MONEY aasimakopoulos Mon, 05/15/2023 - 16:06 Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 billion , without, for the most part, shorter development timelines. Altasciences has U.S.

Drug Development 52

Drug Development Clinical Trials Compounding Pharmacies Laboratories 52

Agency IQ

MARCH 25, 2024

Requirements for 503A pharmacies have since been updated, most notably under the Drug Quality and Security Act ( DQSA ) of 2013, which established new requirements for 503A pharmacies as well as a new category of compounding pharmacies, known as outsourcing facilities (503B pharmacies). suppositories).

FDA 40

FDA Pharmacy Production Drugs 40

Agency IQ

FEBRUARY 15, 2024

We have tried to sort guidance documents by topic area. Priority A List.

FDA 40

FDA Science Biosimilars Production 40